Engaging Mobile Prism Adaptation Treatment at Home

Recruiting now NCT05595668

Run by Nova Scotia Health Authority · for All ages · All sexes

What this study is about

Spatial neglect is a common disorder after stroke which leads to problems with noticing or responding to information from the left side of the body or space. This condition has been linked to reduced independence in a wide range of daily life activities including eating, dressing, and mobility. Despite its high prevalence in stroke patients, there is currently no standard of care for spatial neglect. Prism adaptation (PA) is a promising treatment, however, there are limitations to using PA in standard clinical care as it requires daily exposure for at least two weeks, yet access to equipment and supervision is limited. To solve this problem, the investigators have developed a new game-like PA treatment (Peg-the-Mole, PTM) that can be used at home without the need for daily in person therapist set-up and supervision. In this study the investigators aim to evaluate the feasibility and effectiveness of the gamified and portable PA procedure in an inpatient and home setting, with the hypothesis that the PA procedure will improve patient's neglect symptoms.

Who can join (things the study team will check)

✅ You may be able to join if…

Have experienced a right hemisphere stroke (confirmed by a clinician)
Experience mild to severe symptoms of neglect
Be willing and able to consent to participate
Be medically stable
Have self-reported normal to corrected-to-normal vision
Be able to point to targets presented on a computer screen
Live within a two-hour radius of Halifax

Where this trial is running

Nova Scotia Health Early Supported Stroke Discharge Team, Bedford, Nova Scotia, Canada
Nova Scotia Rehabilitation and Arthritis Centre (NSRAC), Halifax, Nova Scotia, Canada
Nova Scotia Rehabilitation and Arthritis Centre, Halifax, Nova Scotia, Canada
Valley Regional Hospital, Kentville, Nova Scotia, Canada

Who to contact

Anne Sophie Champod, PhD · 9028176871 · anne.champod@acadiau.ca

It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT05595668.

Open the interactive checklist for this trial →

Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.

Beacon is an information tool, not medical advice. Whether a trial is right for you is a decision for you, your doctor, and the study team. Trial details come from the official registry, ClinicalTrials.gov, and may change — always confirm with the study team. Beacon collects no data about you: this page has no cookies, no accounts, and no tracking.